BRK protein tyrosine kinase and encoding nucleic acid
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 18, 2000
Grant Date -
N/A
app pub date -
Jun 10, 1996
filing date -
Jul 9, 1993
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The invention relates to a novel tyrosine kinase designated brk and the use of this tyrosine kinase in the development of diagnostic and therapeutic approaches to cancer. The novel tyrosine kinase was isolated from a human metastatic breast tumor using a PCR based differential screening approach and has the deduced amino acid sequence shown in SEQ ID NO:2.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully